Evidence map›Paper›PMID 38451098›Full record

ArticleMicrobiology spectrum2024

Implementation of a high-throughput whole genome sequencing approach with the goal of maximizing efficiency and cost effectiveness to improve public health.

Michelle C Dickinson, Samantha E Wirth, Deborah Baker, Anna M Kidney, Kara K Mitchell, Elizabeth J Nazarian, Matthew Shudt, Lisa M Thompson, Sai Laxmi Gubbala Venkata, Kimberlee A Musser and 1 more

Abstract read
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Predicting isoniazid resistance inJournal of clinical microbiology · 2026
    Article
  4. Genomic and clinical determinants of extraintestinalmedRxiv : the preprint server for health sciences · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Whole genome sequencing of neurotoxin-producingFrontiers in public health · 2025
    Article
  9. Investigation of invasiveFrontiers in public health · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Michelle C Dickinson *Wadsworth Center, New York State Department of Health (NYSDOH), Division of Infectious Diseases Bacteriology Laboratory, Albany, New York, USA.ORCID 0000-0003-4382-8003
Samantha E Wirth *Wadsworth Center, New York State Department of Health (NYSDOH), Division of Infectious Diseases Bacteriology Laboratory, Albany, New York, USA.
Deborah BakerWadsworth Center, New York State Department of Health (NYSDOH), Division of Infectious Diseases Bacteriology Laboratory, Albany, New York, USA.
Anna M KidneyWadsworth Center, New York State Department of Health (NYSDOH), Division of Infectious Diseases Bacteriology Laboratory, Albany, New York, USA.
Kara K MitchellWadsworth Center, New York State Department of Health (NYSDOH), Division of Infectious Diseases Bacteriology Laboratory, Albany, New York, USA.
Elizabeth J NazarianWadsworth Center, New York State Department of Health (NYSDOH), Division of Infectious Diseases Bacteriology Laboratory, Albany, New York, USA.
Matthew ShudtWadsworth Center, New York State Department of Health (NYSDOH), Advanced Genomic Technologies Cluster, Albany, New York, USA.
Lisa M ThompsonWadsworth Center, New York State Department of Health (NYSDOH), Division of Infectious Diseases Bacteriology Laboratory, Albany, New York, USA.
Sai Laxmi Gubbala VenkataWadsworth Center, New York State Department of Health (NYSDOH), Division of Infectious Diseases Bacteriology Laboratory, Albany, New York, USA.
Kimberlee A MusserWadsworth Center, New York State Department of Health (NYSDOH), Division of Infectious Diseases Bacteriology Laboratory, Albany, New York, USA.ORCID 0000-0003-1922-5405
Lisa MingleWadsworth Center, New York State Department of Health (NYSDOH), Division of Infectious Diseases Bacteriology Laboratory, Albany, New York, USA.

Funding

Whole Genome Sequencing to support GenomeTrakr-Discipline A: Microbiology- Track 4U19FD007089 · FDA · WADSWORTH CENTER · PI EGAN, CHRISTINA, PARSONS, PATRICK J. · 2020 to 2024
$4.5M
FDA HHS U19 FD007089NCEZID CDC HHS U50 CK000423
6 · The paper itself

Abstract

This manuscript describes the development of a streamlined, cost-effective laboratory workflow to meet the demands of increased whole genome sequence (WGS) capacity while achieving mandated quality metrics. From 2020 to 2021, the Wadsworth Center Bacteriology Laboratory (WCBL) used a streamlined workflow to sequence 5,743 genomes that contributed sequence data to nine different projects. The combined use of the QIAcube HT, Illumina DNA Prep using quarter volume reactions, and the NextSeq allowed the WCBL to process all samples that required WGS while also achieving a median turn-around time of 7 days (range 4 to 10 days) and meeting minimum sequence quality requirements. Public Health Laboratories should consider implementing these methods to aid in meeting testing requirements within budgetary restrictions. IMPORTANCE: Public Health Laboratories that implement whole genome sequencing (WGS) technologies may struggle to find the balance between sample volume and cost effectiveness. We present a method that allows for sequencing of a variety of bacterial isolates in a cost-effective manner. This report provides specific strategies to implement high-volume WGS, including an innovative, low-cost solution utilizing a novel quarter volume sequencing library preparation. The methods described support the use of high-throughput DNA extraction and WGS within budgetary constraints, strengthening public health responses to outbreaks and disease surveillance.

Indexed as

Cost-Effectiveness AnalysisPublic HealthDNAGenome, BacterialGoalsHigh-Throughput Nucleotide SequencingWhole Genome SequencingDNADNA extractionhigh throughputIlluminalab efficiencyNextSeqpublic healthPulseNetQIAcubeHTQuarter Library PrepWadsworth Centerwhole genome sequencingworkflow

Identifiers

PMID38451098
PMCPMC10986607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.